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Short Treatment and the WHO Pneumonia - What are We
Treating?
Z. Bhutta
The Aga Khan University, Karachi, Pakistan
It is estimated that there are 5-9 episodes of acute respi-
ratory infections (ARI) per year / under 5 children, the vast
majority of which are viral. Some 2-3% of these episodes
represent pneumonia and between 7-13% (some 11-17 mil-
lion acute lower respiratory infections are severe enough to
require hospital admission.
Despite numerous advances in understanding the burden
and epidemiology of childhood respiratory pneumonia, the
disorder still accounts for almost 1.8 million child deaths
annually, 98% in developing countries. It is widely stated
that in developing countries, most pneumonia is bacterial
and most acute respiratory infection related deaths are due
to pneumonia, however, the exact proportion of these infec-
tions which are related to viral or bacterial infections is
unclear. Given the high burden of deaths in young children,
WHO has progressively developed algorithms for the diag-
nosis and management of acute respiratory infections based
on clinical criteria of fast breathing and chest indrawing.
These criteria have been used for the diagnosis and therapy
of pneumonia in a range of settings. In recent years, the suc-
cess of short course antibiotic therapy of such episodes has
opened the possibility of improving community case man-
agement of such infections and reducing rates of resistance.
However, a legitimate question has been raised as to the
nature of acute respiratory infections diagnosed by the WHO
algorithms. This presentation will review the current state
of knowledge in relation to the etiology and outcomes of res-
piratory infections in children in developing countries and
also discuss the implications for research and programs.
Our ﬁndings indicate that the current criteria for deﬁning
pneumonia as suggested by WHO are too broad and proba-
bly include a host of conditions, including viral infections
and asthma, which do not require antibiotics. A much more
effective and validated deﬁnition and clinical description of
pneumonia is needed for programmatic settings.
doi:10.1016/j.ijid.2010.02.1555
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Can Short Antibiotic Treatment be Widely Used in Devel-
oped Countries
R. Dagan
Beer Sheva University, Beer-Sheva, Israel
Childhood pneumonia is the most common killer of
children <5 years worldwide. Although in the developed
world pneumonia does not commonly result in death, it
is an extremely common disease. Treatment is almost
universally with antibiotics. However, the lack of appro-
priate deﬁnition of pneumonia, the difﬁculty in diagnosing
the pathogen and cultural differences make it extremely
difﬁcult to agree on the ideal treatment. A short antibi-
otic course is preferred to a longer one, since if equally
effective, it should be associated with lower cost, less
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dverse events and lower rates of antibiotic resistance
n the community. An extensive literature search using
combination of the words ‘‘pneumonia’’, ‘‘community-
cquired’’, ‘‘treatment’’, ‘‘drug’’, ‘‘antibiotic’’, short’’,
‘shortened’’, ‘‘day (s)’’, and ‘‘child’’ resulted in a few
rticles only dealing with short duration treatment of pneu-
onia in children, all in the developing world and most
ealing with pneumonia deﬁned by the WHO criteria (used
n locations where no modern medicine can be applied). We
ndertook a prospective, double blind, randomized study,
omparing high-dose amoxicillin (80mg/kg) administered
or 5 vs. 10 days in children with community-acquired alve-
lar pneumonia with the following inclusion criteria: 1) <5
ears old; 2) radiologically proven alveolar pneumonia; 3)
emperature ‘‘38.5 ◦C; 4) peripheral WBC’’ 15,000/mm3.
e followed the children both clinically and with labora-
ory ﬁndings for a month. The study will be unblinded after
anuary 31st and the preliminary results will be presented.
In conclusion: Paucity of data and difﬁculty in deﬁning
hildhood pneumonia in the developed world result in confu-
ion in regard to short treatment. However, the ﬁrst studies
ill reveal, at least in some deﬁned subgroups of pneu-
onia, the efﬁcacy and the potential use of short-course
reatment in childhood pneumonia.
oi:10.1016/j.ijid.2010.02.1556
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linico epidemiologic and molecular characterization of
etallo beta lactamases (MBLs) producing nosocomial
seudomonas aeruginosa (PSA)
. Chatterjee1,∗, A. Kumar2, K.N. Prasad3, D. Mathai1, A.
anoharan1
Christian Medical College and Hospital, Vellore, Tamil
adu, India
Amrita Institute of Medical Science, Kochi, India
Sanjay Gandhi Post Graduate Institute of Medical Sciences,
ucknow, India
Background: The high prevalence of co-resistance to
etalactam, aminoglycoside and quinolone against PSA has
ecessitated increased use of carbapenems. MBL production
mong PSA is one of the several mechanisms causing car-
apenem resistance (CARB-R) transferable by integrons. We
urveyed MBL production among PSA isolates collected via
ulticentric surveillance study.
Methods: During March-September 2009 BMPLIII received
5 consecutively collected PSA causing infections of (skin
nd soft tissue-48, blood and respiratory tract 11 each,
nd other sites, 5) from four (50-AIMS,Kochi, 21-SGPGIMS,
-MGIMS,2-AIIMS,Delhi) Indian Medical centers. Antimicro-
ial susceptibility testing by Kirby Bauer method against
eftazidime (CZD), cefepime(FEP), piperacillin/tazobactam
TZP), ticarcillin /clavulanic acid (TIM), gentamicin
GEN), amikacin(AK), ciproﬂoxacin(CIP), imipenem(IMP),
eropenem(MEM), aztreonam(ATM) and colistin(CL) was
one. MBL was screened by the Combined Disk Diffusion Test
CDDT) method using 0.5 M EDTA (930g) as the inhibitor
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ith IMP, positives (inhibition ≥7 mm) conﬁrmed by IMP +
DTA Etest and PCR (VIM and IMP genes).
Results: Of the 75 PSA isolates, 12(16%) were MBL
roducers. Diabetes mellitus was found to be the major risk
actor in PSA infections. Overall resistance to CIP 50.7%>
ZD 37.3% >AK 36%> FEP 34.7%. Resistance pattern among
BL/NMBL was CZD(91.7%/23.8%), FEP(91.7%/20.6%),
ZP(91.7%/15.9%), TIM(100%/27%), GEN(100%/23.8),
K(100%/20.6%), CIP(100%/38.1%), IMP(100%/6.3%),
EM(75%/9.5%), ATM(91.7%/38.1%). Resistance to IMP
nd MEM was 22.7% and 21.3% respectively. All isolates
ere susceptible to CL. MDR (resistant to ≥2 classes of
ntimicrobials) was 34(45.3%).Overall 14(18.7%) were CDDT
ositive. IMP + EDTA Etest and PCR conﬁrmed 12 to be MBL
ositives. Among the MBL isolates, one was also positive
or IMP gene, which on sequencing was conﬁrmed to be
MP 7. Sensitivity and speciﬁcity of CDDT was 100% and
6.8% respectively when compared to PCR. History of prior
ntibiotic usage of aminoglycosides (66.7%), 3rd generation
ephalosporins (58.3%), quinolones (58.3%), carbapenems
50%), penicillins (25%), betalactam + betalactamase
nhibitors (8.3%) was noted for the patients with MBL
nfection. Clinical improvement or cure with modiﬁcation
f initial antibiotics was found in 63.6% (7/11) patients with
BL PSA.
CR for VIM and IMP gene in PSA
onclusion: MBL production is an important mechanism of
ARB-R among PSA. Spread should be further minimized by
sing carbapenems judiciously in the treatment of PSA infec-
ions. CDDT is a useful method for screening MBL. VIM type
f MBL was seen among all MBL positive isolates.
oi:10.1016/j.ijid.2010.02.1557
l
A
a
C
f
o
f
P
o
s
d
f
i
c
e
dternational Congress on Infectious Diseases (ICID) Abstracts
3.002
he resistance patterns of Pseudomonas aeruginosa in
ospitals from Greece and Romania and its importance for
he therapy of nosocomial infections and infection control
ractices
.M. Junie1,∗, S. kastanakis2, M. Petrascu1, C. Bobos¸ 1, A.
souri 2, P. Karagianni2, E. Papadomanolaki 2, G. Aleuraki 2,
. Gatzima2, I. Varthalitis 3
University of Medicine and Pharmacy, Cluj Napoca, Roma-
ia
St. George General Hospital, Chania, Greece
Infection Control Committee, Chania, Greece
Background: One of the most difﬁcult problems in
ospitals is the appearance of an increased number of Pseu-
omonas antibiotic resistant strains. The objective of our
tudy is to describe the resistance pattern of Pseudomonas
eruginosa strains.
Methods: For isolating Pseudomonas aeruginosa strains,
he usual nutritive media were used. Identiﬁcation was
ade with Vitek2 system (BioMerieux). The susceptibility
o the antibiotics of strains was performed by Kirby Bauer
ethod as recommended by CLSI and Vitek2 system. Were
ested 229 strains isolated from urine and surgical wounds,
n Cluj Napoca, Romania, and 36 strains isolated from blood
amples in Chania, Greece. The majority of the strains
86.1%) were isolated from patients in wards and a percent-
ge of 13.8 from Intensive Care Unit.
Results: The strains isolated in Romania from urine
howed a high resistance to betalactamins, remaining sus-
eptible to Carbenicillin, Carbapenems, Ceftazidime and
efepime. Over 80% of the strains, were resistant to oth-
rs of third generation cephalosporins. The strains isolated
rom blood, presented resistance to Aztreonam (30.43%)
nd Ceftazidime (13%). 13% were resistant to Imipenem
nd Meropenem. Pseudomonas aeruginosa isolated strains
n Romania, showed resistance to Amikacin (71.4% iso-
ated strains from urine and 29.7% from surgical wounds),
nd a low resistance to Gentamycin (18.6%), Tobramycin
25%). 29.6% were resistant to Colistin. The strains iso-
ated in Chania, showed resistance to Gentamycin (21.4%).
ll strains isolated from urine, were resistant to Peﬂoxacin
nd a high resistance was detected to Nalidixic acid (75%),
iproﬂoxacin (75%) and Oﬂoxacin (50%). The strains isolated
rom surgical wounds, presented a resistance to quinolones,
scillating between 33.1% and 51.9%. The isolated strains
rom blood showed resistance to Nalidixic acid (38.5%),
eﬂoxacin (38.5%) and Ciproﬂoxacin (38.5).
Conclusion: Our results could reﬂect the implication
f some hospital multi resistant Pseudomonas aeruginosa
trains in nosocomial infections. In Greece, a decline in
rugs resistance of Pseudomonas strains has been noted. As a
act, it is rather encouraging, and probably we can attribute
t to adherence to infection control practices and prudent
hemotherapeutic agents use as proposed by Infectious Dis-
ases Control Committee. The majority of the strains was
etected in ward patients and owing to reduced morbidity
